Vivos Therapeutics Inc (VVOS)

$4.43 +0.60 (15.67%)
Market Cap 26.09M
Revenue (ttm) 15.03M
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -74.12%
Debt to Equity Ratio 0.00
Volume 994,400
Avg Vol 762,054
Day's Range N/A - N/A
Shares Out 5.89M
Stochastic %K 87%
Beta 7.01
Analysts Sell
Price Target $4.22

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Address:
7921 Southpark Plaza, Suite 210, Littleton, United States
Lizardbronsen
Lizardbronsen Jul. 6 at 10:04 PM
$VVOS
0 · Reply
GSP
GSP Jul. 6 at 6:55 PM
I like the way $VVOS is already curling back up near Tuesday's high after it sold off after gapping up. I'll be watching it this week. .
0 · Reply
ChartChartist
ChartChartist Jul. 6 at 6:14 PM
$WKHS nearing blue skies $VVOS thursday green daily was strong $AISP flag on daily $ pmax top trending on reddit , its getting traded dont miss out on banking
0 · Reply
Muskvoice
Muskvoice Jul. 6 at 11:41 AM
$VVOS BULL CASE THEORY EVEN AT 40$/Share this will be only a 200M$ Market cap stock.... Weekly Chart.
1 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 3:17 AM
@VVOS
0 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 2:19 AM
Vvos
0 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 1:37 AM
$VVOS
0 · Reply
Muskvoice
Muskvoice Jul. 6 at 1:28 AM
$VVOS
1 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 1:25 AM
Vvos
0 · Reply
kemsma62
kemsma62 Jul. 4 at 8:21 AM
$VVOS There were some good buys at the end of yesterday’s session. 👇🤞🍀
0 · Reply
Latest News on VVOS
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Jun 26, 2025, 8:30 AM EDT - 10 days ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 15, 2025, 7:31 PM EDT - 7 weeks ago

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

May 14, 2025, 9:15 AM EDT - 7 weeks ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Apr 16, 2025, 8:30 AM EDT - 2 months ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 12:18 AM EDT - 3 months ago

Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 31, 2025, 4:20 PM EDT - 3 months ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Mar 28, 2025, 8:30 AM EDT - 3 months ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 23, 2024, 8:00 AM EST - 6 months ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:31 PM EST - 8 months ago

Vivos Therapeutics, Inc. (VVOS) Q3 2024 Earnings Call Transcript

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Nov 13, 2024, 5:00 PM EST - 8 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Oct 8, 2024, 7:30 AM EDT - 9 months ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Sep 18, 2024, 7:00 AM EDT - 10 months ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 2:05 PM EDT - 11 months ago

Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 4:05 PM EDT - 11 months ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Aug 14, 2024, 7:30 AM EDT - 11 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 27, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Jun 12, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

May 17, 2024, 9:02 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q1 2024 Earnings Call Transcript

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

May 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 11:10 PM EDT - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Mar 28, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Feb 6, 2024, 7:30 AM EST - 1 year ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Jan 8, 2024, 7:30 AM EST - 1 year ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Dec 11, 2023, 7:30 AM EST - 1 year ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 11:09 AM EST - 1 year ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:44 AM EST - 1 year ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 29, 2023, 7:30 AM EST - 1 year ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript

Nov 17, 2023, 7:12 PM EST - 1 year ago

Vivos Therapeutics, Inc. (VVOS) Q3 2023 Earnings Call Transcript

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 14, 2023, 4:05 PM EST - 1 year ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 9, 2023, 4:30 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Vivos Therapeutics Closes $4 Million Private Placement

Nov 2, 2023, 5:00 PM EDT - 1 year ago

Vivos Therapeutics Closes $4 Million Private Placement

Vivos Therapeutics Announces Reverse Stock Split

Oct 26, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Reverse Stock Split

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Oct 24, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Oct 11, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Oct 5, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

Oct 4, 2023, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Oct 2, 2023, 7:30 AM EDT - 1 year ago

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Aug 16, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

Aug 16, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

Aug 14, 2023, 5:06 PM EDT - 2 years ago

Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call

Aug 10, 2023, 8:31 PM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call

Vivos Therapeutics, Inc. (VVOS) Q1 2023 Earnings Call Transcript

Jun 9, 2023, 12:24 PM EDT - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q1 2023 Earnings Call Transcript

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

Jun 8, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call

Jun 6, 2023, 4:30 PM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call

Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos' POD® Appliance Treatment

May 1, 2023, 7:30 AM EDT - 2 years ago

Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos' POD® Appliance Treatment

Vivos Therapeutics, Inc. (VVOS) Q4 2022 Earnings Call Transcript

Mar 31, 2023, 6:05 PM EDT - 2 years ago

Vivos Therapeutics, Inc. (VVOS) Q4 2022 Earnings Call Transcript

Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update

Mar 30, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update

Lizardbronsen
Lizardbronsen Jul. 6 at 10:04 PM
$VVOS
0 · Reply
GSP
GSP Jul. 6 at 6:55 PM
I like the way $VVOS is already curling back up near Tuesday's high after it sold off after gapping up. I'll be watching it this week. .
0 · Reply
ChartChartist
ChartChartist Jul. 6 at 6:14 PM
$WKHS nearing blue skies $VVOS thursday green daily was strong $AISP flag on daily $ pmax top trending on reddit , its getting traded dont miss out on banking
0 · Reply
Muskvoice
Muskvoice Jul. 6 at 11:41 AM
$VVOS BULL CASE THEORY EVEN AT 40$/Share this will be only a 200M$ Market cap stock.... Weekly Chart.
1 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 3:17 AM
@VVOS
0 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 2:19 AM
Vvos
0 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 1:37 AM
$VVOS
0 · Reply
Muskvoice
Muskvoice Jul. 6 at 1:28 AM
$VVOS
1 · Reply
Marekbogdan
Marekbogdan Jul. 6 at 1:25 AM
Vvos
0 · Reply
kemsma62
kemsma62 Jul. 4 at 8:21 AM
$VVOS There were some good buys at the end of yesterday’s session. 👇🤞🍀
0 · Reply
HushMoney
HushMoney Jul. 3 at 11:46 PM
$VVOS Everyone is looking forward to Q2/2025 numbers here in the US but nobody ever mentions there Partnership agreement in the Middle East/North Africa that should be showing revenues in Q3&4 2025. The worldwide adoption of this technology will send this into Orbit. Let the penny flippers have there fun, I'm in for the long haul and the 20x bagger this could easily be!
1 · Reply
PaddyIce87
PaddyIce87 Jul. 3 at 10:44 PM
$VVOS Float is locked. Tiny MC. Recent good news and more to come. She moves bigly. Longs been sayin’. We will see sixes soon. History of big runs $40+, $80+ respectively. NFA DYOR.
0 · Reply
Muskvoice
Muskvoice Jul. 3 at 10:28 PM
$VVOS $CLOV $MVST $TSLA TARGET SHORT SELLERS "STOP LISTENING TO STUPID ADVISE...." 07/04/2025 https://youtu.be/CzwxhV6vhSk?si=IzUpMxGa4eAZUKCT
1 · Reply
BlueTeam7
BlueTeam7 Jul. 3 at 8:53 PM
$VVOS waiting patiently
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 3 at 7:32 PM
$VVOS has soared 4% higher to 15% (~981Kv) moments ago, follow for more volatility.
0 · Reply
Muskvoice
Muskvoice Jul. 3 at 7:18 PM
$VVOS Anybody who sell under 12$ will have deep regrets
1 · Reply
ka1954
ka1954 Jul. 3 at 6:26 PM
$VVOS why u idiots selling in after hours, dont sell before market closed?
0 · Reply
Teddyp1974
Teddyp1974 Jul. 3 at 6:22 PM
$VVOS this after hours on low volume means nothing, right?
1 · Reply
rxptgh
rxptgh Jul. 3 at 6:13 PM
$VVOS there’s the 1 bagger
0 · Reply
ACInvestorBlog
ACInvestorBlog Jul. 3 at 5:52 PM
$VVOS closed with a Big bullish candle. Watching the break of 4.68 next week for a run into $6S
0 · Reply
bninawhile
bninawhile Jul. 3 at 5:37 PM
$VVOS fantastic week everyone. What a surprise show of strength as well as amazing news. Happy fourth. Can’t wait to see this Lee going
0 · Reply
kemsma62
kemsma62 Jul. 3 at 5:16 PM
$VVOS Whatta day! 🍀💥 Regular session ended at 1:00 PM ET due to the July 4 holiday! After-hours session will start afterward, from 4:00 PM to 8:00 PM ET!
2 · Reply